Delivery Order SPE2DB22D2206-SPE2DB24FKL72

Award Date 9/24/24
Potential Completion Date 9/25/24
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets. The contract has an ultimate completion date of January 24, 2025 and a ceiling value of $15,714.20. AmerisourceBergen is a major pharmaceutical distributor that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a wide range...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets. The contract has a ceiling value of $35,632.27 and an ultimate completion date of October 15, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription medications to support military treatment facilities and other government healthcare providers. The contract is not set aside for any...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,178.51, is for the delivery of Candesartan Cilexetil 32 mg tablets to support military healthcare programs. The contract is a Firm Fixed Price arrangement with a completion date of June 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a $23,928.65 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets. The contract has an ultimate completion date of April 3, 2025 and is a firm fixed-price contract. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $3,734.76, is for the supply of Candesartan Cilexetil 8 mg tablets. The contract has an ultimate completion date of April 23, 2025 and is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corporation holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $5,837.28 fixed-price contract is for the delivery of Candesartan Cilexetil 32 mg tablets. There is no set-aside designation for this award. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999, to provide a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $5,528.55 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 32 mg Candesartan Cilexetil tablets in 90-count bottles, with a completion date of September 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999, which provides a range of...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 32 mg tablets in 90-count packages. The contract has a firm fixed price of $15,438.32 and an ultimate completion date of June 10, 2025. This contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a large Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,239.74, is for the delivery of 4,567,908,195 units of Candesartan Cilexetil 32 mg tablets. The contract has an ultimate completion date of April 15, 2025 and is a firm fixed-price arrangement. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of 32 mg Candesartan Cilexetil tablets, a pharmaceutical product, and has a ceiling value of $14,864.29. The contract is a firm-fixed price delivery order with an ultimate completion date of October 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S....
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FKL72
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Candesartan Cilexetil 32 mg tablets. The contract, valued at $4,504.88, has a firm fixed-price pricing type and an ultimate completion date of September 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this order. The contract does not have a set-aside designation. AmerisourceBergen also holds several indefinite delivery contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000, respectively, for the provision of a wide range of pharmaceutical and medical supplies to support federal healthcare programs and facilities.

Generated 12/24/24, 9:22 AM